We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations

News   May 02, 2013

 
Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations
 
 
 

RELATED ARTICLES

Reversing Memory Loss Linked to Depression and Aging

News

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

READ MORE

Animal Venoms Aid the Search for New Medicines

News

Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.

READ MORE

Rare Tumor Cell Type Unable to Synthesize Cholesterol

News

A rare tumor type has been discovered that is unable to synthesize cholesterol, a molecule without which cells can’t survive.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE